Symposium „Genetics and Epigenetics of Haematological Malignancies“ 20-22 November 2024 – Josep Carreras Institute

май 10, 2024 | Научни прояви, Новини

Dear colleagues,

We are happy to announce that the Josep Carreras Leukaemia Research Institute is organizing an international symposium onHaematology Research. The Symposium “Updates on Genetics and Epigenetics of Haematological Malignancies: From Knowledge to Applications” will take place on 20-22 November 2024 at the Josep Carreras Institute headquarters, in Badalona (Barcelona, Spain), and will include lectures and discussions of world-renowned experts. Online attendance is also available.

Please find attached the agenda. You will find more information and the registration link here: Participants are invited to submit abstracts for selection for short talks and poster presentations.

This Symposium is organized by Dr. Manel Esteller, Dr. Anna Bigas, Dr. Laura Belver and Dr. Marcus Buschbeck

We will also have an exceptional panel of international speakers: Iannis Aifantis, New York University (NYU); Francesco Bertoni, Institute of Oncology Research (Ior); Anna Bigas, Josep Carreras Leukaemia Research Institute (IJC) and Hospital del Mar Research Institute; Vincenzo Calvanese, Josep Carreras Leukaemia Research Institute (IJC); Jan Cools, KU Leuven, Center for Human Genetics; Matteo Della Porta, Humanitas Cancer Center; Courtney DiNardo, MD Anderson; Manel Esteller, Josep Carreras Leukaemia Research Institute (IJC); Florian H. Heidel, Hannover Medical School (MHH); Ross Levine, Memorial Sloan Kettering Institute; Ari Melnick, Weill Cornell Medicine; Michael Milsom, German Cancer Research Center (DKFZ); Teresa Palomero, Columbia University; Bruno Paiva, Cima Universidad de Navarra, Research Center (CIMA); Christoph Plass, German Cancer Research Center (DKFZ); Alberto Orfao, University of Salamanca; Brigitte Schlegelberger, Hannover Medical School (MHH); Maria L. Toribio, Centro de Biología Molecular „Severo Ochoa“ and George Vassiliou, Wellcome-MRC Cambridge Stem Cell Institute.